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Solid phase peptide synthesis is the common approach used today in synthesizing peptides in 
a research scale and production. Success in this approach are governed by several factors. 
These are; (1) the solid support on which synthesis is to be carried out, (2) linker/spacer on 
which the first amino acid is linked to the support to allow stepwise growth of the peptide 
chain, (3) protecting groups of amino acids to allow a clean synthesis without disruption of 
the growing peptide chain and (4) coupling reagents for improved amide bond formation 
yielding peptides in the shortest amount of time and with the highest quality. The following 
thesis shows work conducted on some of these aspects. Chapter two is based on the 
application of a novel resin Fmoc-Rink-Amide PEG Octagel surface resin. Chapter three 
describes the development of a novel protecting group for histidine amino acid. 
A new PEG-PS based resin called Octagel has been developed by Aapptec. Fmoc-Rink-Amide 
Octagel PEG surface resin is a unique highly uniform surface-active resin. To study the resin’s 
performance, two peptides Aib-enkephalin pentapeptide and Aib-ACP decapeptide were 
synthesized and results were compared to Polystyrene and ChemMatrix resins. Swelling and 
microscope imaging studies were also conducted on each of the resins to highlight their 
performance associated with Solid Phase Peptide Synthesis. Results have demonstrated that 
Octagel resin has the potential to synthesize peptide sequences with high purity and therefore 
to be a good alternative to those currently in the market. 
Histidine is an important amino acid used in SPPS. It contains a reactive imidazole side group 
that can cause side reactions in SPPS if left unprotected. Fmoc-based SPPS is the most 
commonly used strategy in synthesizing peptides today. A protecting group was created for 
Fmoc-Histidine. SPPS was carried out on the protected histidine and results show that the group 
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The synthesis of peptides has great importance in the field of medicinal chemistry and 
pharmaceutical research. A peptide is made by linking amino acids together through peptide 
bonds. A peptide bond is formed by coupling two amino acids, one is protected at its amino 
end and the other at the carboxylic end. The first free peptide (glycylglycine) was formed in 
1901 by Emil Fischer and was in solution [1]. In solution phase peptide synthesis, after each 
coupling of an amino acid, the intermediate peptide is isolated, purified and characterized 
before the next amino acid is attached. This is a long and tedious process and has disadvantages 
such as low solubility of the intermediate peptides and low yield.  
Solid-Phase Peptide Synthesis (SPPS) was developed in 1963 by R. Bruce Merrifield [2] as an 
efficient method in synthesizing peptides. This development uses a solid support to which the 
growing peptide is bound. Compared to solution phase synthesis, SPPS is a simple technique 
that creates peptides rapidly and efficiently with high purity and high yield. The strategies used 
in solution phase have been adapted to work in solid phase.  
The main component of SPPS is the solid support used to grow the peptide chain. Ever since 
the invention of SPPS, many research groups have made various types of resins to improve the 
quality of peptides. In chapter two, a novel support developed by Aaptec Biotechnology will 
be discussed. Fmoc-Rink-Amide Octagel PEG resin is a surface-active resin that contains 
polyethylene glycol (PEG) chains on its surface. A comparative study was conducted with 
Fmoc-Rink-Amide Aminomethyl Polystyrene and H-Rink-Amide ChemMatrix resins. SPPS 
of ‘difficult’ peptides, Aib-pentapeptide and Aib-ACP decapeptide was carried out on each 
resin. Also, swelling of each resin under different solvents were tested and SEM and light 
microscope images of the resins also conducted.  
Amino acids are trifunctional molecules that requires protecting groups to block the reactivity 
of functionalities to ensure a clean formation of the desired peptide. Among the 20 essential 
amino acids found in nature, few contains reactive side chains that can undergo side reactions 
during SPPS, e.g. arginine, histidine, tryptophan, aspartic/glutamic acids, lysine. Histidine is 
an important amino acid used in peptide synthesis. It contains a reactive imidazole side group 
that can cause side reactions in SPPS if left unprotected. Fmoc-based SPPS is the most 
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commonly used strategy in synthesizing peptides today as it is a mild approach compared to 
Boc synthesis. In chapter three the development of a novel protecting group for histidine amino 
acid and its use in Fmoc – SPPS will be discussed. 
 
1.1 Solid Phase Peptide Synthesis 
 
In 1901, the first ever free peptide was synthesized by Emil Fischer and the reaction was done 
in solution[1]. For a peptide to be synthesized, there are few chemical requirements needed by 
amino acids. A peptide is synthesized by protecting the carboxylic group of one amino acid 
and the amino group of the second amino acid. The activation of the free carboxyl group results 
in the formation of a peptide (amide) bond between the amino acids and the selective removal 
of the protecting groups results in a dipeptide (scheme 1). 
 
 
Scheme 1: General chemical reaction of peptide synthesis 
 
Peptide synthesis in solution is limited because each intermediate step of its synthesis must be 
isolated, purified and characterised before attaching the next amino acid. This time-consuming 
and laborious approach results in low yield and low solubility of the intermediate peptides with 
the increase in the peptide chain length. A new approach was needed to synthesize peptides 
more efficiently as there was a growing need to create larger and more complex peptides with 
high yield and high purity. 
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In 1963, R. Bruce Merrifield developed a ground-breaking concept called Solid Phase Peptide 
Synthesis (SPPS)[2]. In SPPS, the peptide is synthesized in a stepwise manner while the C-
terminal end of the peptide was anchored to an inert cross-linked polymer support and the 
peptide is synthesized from the C-terminal towards the N-terminal (C-N synthesis). 
Concurrently with Merrifield, Letsinger and Kornet developed a “popcorn polymer support” 
and synthesized a dipeptide L-leucylglycine[3]. Their strategy was poorly accepted as they 
anchored the N-terminal of an amino acid to the support. This N-C direction of synthesis does 
not allow cleavage of the peptide from the support under mild conditions and always had the 
possibility of racemisation during synthesis. Merrifield’s concept was accepted as a new 
technique of peptide synthesis and is the most used approach in synthesizing peptides today. 
Merrifield used a chloromethylated copolymer of a nitrated polystyrene (PS) and 
divinylbenzene (DVB) as a support and synthesized a model tetrapeptide (scheme 2). A year 
later he improved his method by using Boc-protected amino acids which eliminated the need 
to nitrate the solid support[4]. The chloromethylated copolymer of polystyrene (PS) and 
divinylbenzene (DVB) resin is now known today as the Merrifield resin. 
 
 




1.2. Principles of SPPS 
Peptide synthesis using SPPS is carried out by a series of chemical reactions that occurs in a 
heterogenous reaction mixture using an insoluble polymer support, a soluble protected amino 
acid and a solvent[6]. A peptide is formed in a stepwise manner by first anchoring or loading 
an amino acid onto the solid support at its C-terminus (carboxylic end) with its N-terminus end 
protected (amino end). Thereafter a series of deprotection, washing and coupling reactions on 
the solid support results in the formation of a peptide (Scheme 3). 
 
 
Scheme 3: Flow diagram describing SPPS[7] 
 
The synthesis of peptides using this approach has many advantages over peptide synthesis in 
solution. These are: 
i. The peptide is synthesized while being covalently bounded to an insoluble polymer 
support at its C-terminal. This allows an easy removal of any by-products or excess 
reagents and solvents from the growing peptide. 
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ii. The use of excess reagents drives the reaction to completion on a support. 
iii. There is no mechanical loss of the peptide as it is retained on the polymeric support in 
a single reaction vessel during the whole synthetic process. 
iv. The final peptide sequence is obtained by a single cleavage step at the end of its 
synthesis. In this reaction, the side chain protecting groups are also cleaved resulting in 
a simple work-up and isolation of a peptide. 
v. The process of SPPS physically is simple, quick and lends itself towards automation 
vi. Some resins used in SPPS can be recycled e.g. 2-CTC resin[8] 
 
Despite the several advantages of SPPS, there are some limitations of SPPS which have been 
extensively reviewed throughout the years[9]: 
i. Stability of peptide-resin bond through the various reaction conditions. 
ii. The formation of truncated and error peptide sequences. 
iii. The intra and intermolecular interactions of the growing peptide and the resin beads can 
change the conformation of the peptide within the resin and therefore difficult the 
synthesis 
These problems are overcome with modifications of the SPPS protocol with several 
developments like new polymer supports with improved swelling properties to increase 
solvation of the support and the growing peptide chain and linkers to allow a simple removal 
of the peptide from the support. Also, the development of protecting groups greatly reduces the 
formation of truncated and error peptides. In this chapter we look at some of these 
developments. 
 
1.3. Development of Resins 
The success of SPPS is dependent on a resin and its performance. In the SPPS context, usually 
under the word “resin”, there are two parts: the solid support and a spacer/linker. The solid 
support is considered the heart of SPPS. The main requirement of a solid support is to be 
chemically stable throughout all conditions of the synthesis. Also, it should allow for an easy 




A linker/spacer is a chemical entity that is permanently attached onto a polymer support that 
temporarily links the growing peptide onto the support. Linkers aid in the cleavage of the 
peptide from the support under specific conditions. A large variety of linkers were developed, 
all of which are used in polystyrene core resins. Most of these linkers are cleaved in acidic 
conditions and can result in a modified C-terminal end of a peptide, e.g. peptide acid, amide, 
hydrazine or sulfonamides (Scheme 4). 
 
 
Scheme 4: The concept of a solid support with a linker/spacer which together form the resin  
 
Many supports were developed and used for peptide synthesis, most of which are modifications 
of the common copolymer of polystyrene and divinylbenzene developed by Merrifield whereas 
others were made of polyamide, polyethylene glycol or a mixture of polystyrene with these 
two. However, the most commonly used supports are those based on polystyrene or 
polyethylene glycol or a combination of both. 
 
1.4. Polymer supports 
The Merrifield resin is a copolymer PS-DVB which is chloromethylated. PS is hydrophobic in 
nature and the interactions of amino acids towards the growing peptide can become difficult. 
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Improvements and modifications were conducted on Merrifield’s concept to deal with the rigid 
hydrophobic environment of the PS-DVB matrix. 
Atherton et al developed a polar support, polydimethyl acrylamide resin that has a similar 
structure to the peptide backbone[11-13]. The similarity of the support and the peptide structure 
helps in the solvation of the peptidyl resin. This reduces the steric hindrance of the many 
reactions performed during synthesis (deprotection and coupling). The cross-linked 
polydimethylacrylamide resin was prepared by persulfate initiated emulsion copolymerisation 
of dimethylacrylamide and N,N-bisacryloylethylenediamine in water and cellulose acetate 
butyrate together with Boc-β-alanyl-N-acryloylhexamethylenediamine[14]. Polyacrylamide 
beads are large and swells well in polar solvents like DMF and AcOH but not so well in non-
polar solvents like DCM. The stability of these resins is also less compared to polystyrene 
supports. A copolymer of PEG with polyamide was also developed for SPPS. Bis-2-
acrylamidoprop-1-yl polyethyleneglycol cross-linked dimethyl acrylamide (PEGA) was 
introduced by Meldal et al as a hydrophilic, biocompatible and flexible support for peptide 
synthesis[15]. 
The mixture of PS with PEG polymers are a good class of solid supports. The hydrophobic 
nature of PS together with the hydrophilic polymers of PEG allows for a more stable and 
flexible support for SPPS. Li et al conducted a comparison study of PS resins and PS cross-
linked with PEG of different percentages and observed faster kinetics as the PEG percentage 
increased[16]. There is also high swelling of PS-PEG supports in non-polar solvents like DCM 
and DMF which are suitable solvents used in SPPS. 
Bayer et al created Tentagel which was prepared by grafting ethylene oxide onto PS 
supports[17]. Albericio and Zalipsky developed a support with PEG chains coupled by amide 
bonds onto a suitable amino functionalized PS support[18].  Champion I and II developed by 
Adams et al incorporated PEG chains onto PS by attaching a spacer between them to improve 
stability and loading during SPPS[19]. A copolymer of PS with a tetraethyleneglycol diacrylate 
crosslinker (TTEGDA) was developed by Pillai et al and resembled a gel rather than a solid 
support[20]. It had good swelling and good mechanical properties in automated synthesis of 
larger peptides however, it suffered drawbacks with the crosslinker compared to DVB. A 
highly crosslinked support by Kempe and Barany called CLEAR (cross-linked ethoxylate 




Recently a fully PEG based support was developed by Côté el al called ChemMatrix resin[22]. 
This support is mainly made from primary ether bonds and is highly cross-linked. The 
amphiphilic character of the resin makes it highly stable and biocompatible. In chapter two, 
work conducted on a novel resin by Aaptec Biotechnology called Fmoc-Rink-Amide Octagel 
PEG surface resin will be discussed. 
  
1.5. Linkers 
The so-called Merrifield resin is made up of a copolymer of a chloromethylated polystyrene 
crosslinked with 1% divinylbenzene. The chloromethyl entity of the support acts a linker to the 
peptide and the support. Many linkers were developed to improve the removal of a peptide 
from the solid support. 
Wang developed p-alkoxybenzyl alcohol (1) resin for the synthesis of protected peptides 
having a free carboxyl group and p-alkoxybenzyloxycarbonyl hydrazide (2) resin for the 
synthesis of protected peptide hydrazides (Figure 1)[23]. The p-alkoxy group on the benzyl 
moiety increases the acid lability of the peptide-resin bound where 50 - 90% of trifluoroacetic 
acid (TFA) can cleave the anchoring bond. These supports can be used for peptide synthesis 
using Fmoc-amino acids where the Fmoc groups are removed by an organic base. 
 
 
Figure 1: Wang resin derivatives (1) p-alkoxy benzyl (2) p-alkoxy hydrazide 
 
Mitchell et al also developed a linker to combat the loss of the peptide during cleavage through 
acidolysis[24]. The 4-(hydroxymethyl)phenylacetamidomethyl (PAM) linker is electron 
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withdrawing which makes the ester bond more stable towards acid compared to the 
chloromethyl (Merrifield resin) and, of course, the alkoxy benzyl alcohol resin (Figure 2). 
 
 
Figure 2: PAM resin 
 
Kaiser and DeGrado developed the Kaiser oxime resin is a p-nitrobenzophenone oxime ester 
(Figure 3)[25]. It had a major impact in SPPS for peptides using Boc chemistry. The final 




Figure 3: Kaiser oxime resin 
 
The creation of C-terminal peptide amides from a support began with the development of a 
benzhydrylamine (BHA) linker by Pietta and Marshall[26]. Modifications of this support was 
done by Matseuda and Stewart forming a p-methylbenzhydrylamine (MBHA) resin to improve 
the stability of the support[27].  
With the use of Wang linkers, N-protected Boc groups that are removed with 30% TFA in 
DCM cannot be used because the continuous acidic treatment causes a loss of the peptide from 
the support, and therefore the use of Fmoc for the N-protection was implemented. Fmoc 
protection can also be used with more acid labile linkers, which were created by Sheppard et 
al (4-hydroxymethyl-3-methyoxyphenoxy) acetic acid (HMPA)[28] and 2-methoxy-4-
benzyoloxybenzyl alcohol-based resins (SASRIN by Mergler et al)[29] and (SASRIN-NH2 by 





Figure 4: Acid sensitive linkers (3) HMPA type linker and (4) SASRIN 
 
Rink also created a trialkyloxy-diphenyl-methyl ester amide linker to increase the acid lability 
of supports to create protected peptides[31]. Protected peptides are important for convergent 
peptide synthesis of larger peptides. Rink acid and amide were created to form peptide acids 
or peptide amides respectively (Figure 5).  
 
 
Figure 5: Rink linkers, (5) Rink acid and (6) Rink amide 
 
In 1991, two resins with high acid sensitivity linkers were developed. The 2-chlorotrityl (2-
CTC) resin created by Barlos et al is a high acid sensitive resin [32] that cleaves in 1% TFA 
and links peptides through an electrophilic substitution reaction.  Barany and Albericio 
developed a tris alkoxy benzyl ester linker called HAL (hyper sensitive linker) that is highly 





Figure 6: 2-Chloro trityl resin (7) and hyper sensitive linker (HAL) (8) 
 
1.6. Protecting groups 
In the synthesis of peptides, from a simple dipeptide to larger complexed ones, the functional 
groups of amino acids that are not involved in an amide bond formation should be protected or 
blocked to ensure the correct formation of the desired peptide.  
The first protecting group to be developed for peptide synthesis was in 1932 by Bergmann and 
Zervas called the carbobenzoxy (Cbz or also known as Z)[34]. The carbobenzoxy group was 
used as a temporary α-amino protecting group. This development allowed for several peptides 
to be synthesized in solution such as vasopressin[35] and oxytocin by du Vigneaud et al[36], 
which were the first active peptides synthesized. du Vigneaud and Merrifield, years later, were 
recognized with the Nobel Prize of Chemistry. 
Few years later, Albertson and McKay developed the Boc group as a temporary acid labile 
protecting group[37]. The Boc group was used in combination with Cbz protecting group to 
synthesize many peptides thereafter. The use of Boc was employed by Merrifield in the 
synthesis of Bradykinin[4]. 
The use of Boc protected amino acids was employed in almost every synthetic strategy of 
peptide synthesis however its removal in acid during SPPS at that time also encounter loss of 
the peptide fragments during SPPS, due to the partial instability of the chloromethyl resin with 
the use of acids. 
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The development of Fmoc group by Carpino et al as a base-labile amino protecting group 
mainly for the N-terminal was a great milestone in the synthesis of linear peptides[38]. This 
mild protecting group that is removed under basic conditions such as 20% piperidine in DMF 
is common today in amino acids and is most commonly used in synthesizing peptides. 
Stepwise SPPS has two main types of protection, being temporary and permanent groups. A 
schematic representation (scheme 5) explains these different types of protection. 
 
Scheme 5: SPPS strategy depicting the various types of protection. An adaptation of Scheme 3  
There are two types of protection strategies associated with SPPS; the Boc/Benzyl and Fmoc/t-
Bu strategy. Boc and Fmoc groups act as temporary protecting groups at the N-terminal end of 
the amino acids and are removed under acidic and basic conditions respectively[39]. 
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The Boc/Bzl strategy depends on acid lability and is usually removed with TFA (25-50% in 
DCM). The permanent protecting groups, usually Bzl type functionalities, are removed at the 
end of the synthesis when the peptide is cleaved from the resin under strong acidic conditions 
using hydrofluoric acid (HF) or trifluoromethanesulfonic acid with scavengers like anisole to 
capture the formed carbocations. These harsh conditions can lead to damages to the resultant 
peptide chain and requires special instrumentation to use[39]. The use of the Fmoc/t-Bu 
strategy is a milder approach that uses an orthogonal protection system. The concept of 
orthogonality was introduced by Barany et al and explains that two or more protecting groups 
can be present in a molecule and can be removed in the presence of the other under different 
conditions[40, 41]. Figure 7 explains the orthogonality of Fmoc/t-Bu protection. 
 
Figure 7: The concept of Orthogonality using Fmoc/t-Bu chemistry 
 
1.7. Histidine amino acid 
 
There are 20 common, naturally occurring amino acids that are used for peptide synthesis. Most 
of these amino acids contain reactive side chain groups that can be activated during peptide 
synthesis and requires protecting groups to ensure a clean formation of a peptide e.g. arginine, 
histidine, serine, aspartic/glutamic acids, lysine etc. Table 1 shows examples of some amino 




Table 1: Some examples of side chain reactions that can occur in amino acids without the use 
of protecting groups 
 
Among the many amino acids used in peptide synthesis, histidine has an important presence in 
nature. Histidine is an essential amino acid and is a precursor to histamine, a compound 
released via immune response to fight off allergic reactions. Peptide sequences containing 
histidine have many applications. Histatins, an antimicrobial peptides secreted by the parotid 
and sub-mandibular salivary glands are rich in histidine amino acids[43]. They are known to 
possess anti-fungal and anti-bacterial properties. Histidine rich peptides also show application 
in nucleic acid delivery[44]. Overall, peptides that are rich in histidine have shown great 
potential in biotechnology and nanomedicine[45].  
Histidine is common to cause racemization in peptide synthesis when activated for peptide 
bond formation[42]. This side reaction is more frequent when histidine is used without 
protection of its imidazole side-chain. Hence an unprotected imidazole of histidine, in addition 
to partaking in acylation from an incoming protected amino acid, can cause racemization in 
SPPS. 
The imidazole group of histidine contains two nitrogen atoms which can participate into the 
tautomerization of histidine. These nitrogens are labelled π-N (near the alpha carbon) and τ-N 






















Early works conducted by, Fletcher et al[46] and Jones et al[47] have described mechanisms 
of racemization to be a result of the π-nitrogen. Ways in preventing this racemization to occur 
is to directly protect the π-nitrogen or by protecting the τ-nitrogen with strong electron-
withdrawing group to decrease the basicity of the π-nitrogen. Racemization can occur upon 
amino acid activation for coupling via an intramolecular base catalyzed reaction of the π 
nitrogen[47] (scheme 6) forming an enol. 
 
Scheme 6: Possible mechanism of histidine during racemization 
 
Acylation of the imidazole group can also occur during peptide synthesis which could lead to 
Nτ to α amino group migration (scheme 7). 
 
 
Scheme 7: Acylation of histidine during peptide synthesis with Nτ to α amino group migration 
 
There are many protecting groups developed for histidine amino acid, majority of which protect 
the τ-nitrogen. Protection at the π-nitrogen is hard to achieve and requires several synthetic 
steps which can be tedious and expensive to synthesize. The case of racemisation is still not 
fully resolved, and the development of new protecting groups is essential. Table 2 shows the 
most common functional groups used for histidine with their strengths and drawbacks in their 




Table 2: Protecting groups used for histidine amino acid 
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A brief overview of the imidazole group of histidine has been outlined by J. H. Jones in 
Houben-Weyl Methods of Organic Chemistry[59]. In this, the author explains that the 
basicities of the two imidazole nitrogens are almost the same (pKa ca. 7) yet their reactivity 
towards electrophiles is different and that, in most cases interconversion between substituted 




Scheme 8: The imidazole nitrogen’s reaction towards electrophiles 
 
He also stated that reactions with electrophiles like alkyl halides e.g. benzyl halides with the 
imidazole side chain of histidine produce mixtures of τ-nitrogen and π-nitrogen derivatives 
(scheme 8) with the τ-nitrogen product to be dominant.  
The most commonly used protecting group for Fmoc peptide synthesis is the Trityl (trt) group. 
The Trt moiety is attached to the τ-nitrogen of histidine however its electron withdrawing 
substituents helps in reducing the basicity of the π-nitrogen and its bulkiness helps to minimize 
the abstraction of the -proton, but both effects only to an extent. Also, cleavage of the trityl 
group from histidine occurs in short amount of time, preventing the synthesis of protected 
histidine peptides useful when carrying out convergent peptide synthesis. The tertiary 
butoxymethyl (Bum) protecting group is a suitable replacement, however attachment of this 
group to histidine is a lengthy process which is expensive and during the removal release 
formaldehyde, which can react with the free amine present in the peptide and therefore form 
unnecessary side products.  
Bearing all of this in mind, the development of inexpensive yet improved protecting group(s) 
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Fmoc-RinkAmide PEG Octagel Surface Resin – A new PEG-PS based resin 
 
2.1. Introduction 
Peptides are continuously growing in demand as new potentials of drugs and therapeutics. 
Peptide synthesis using the solid-phase approach has become the most commonly used method 
of synthesizing peptides on a research scale. This approach is seen as a rapid and efficient 
method of obtaining peptides as it uses resins as a medium to synthesize the peptides. However 
not all resins are compactable to synthesize certain peptides. This is due to the polymers used 
in creating the resins as supports. Some polymers interact well with the growing peptide 
allowing for an easy synthesis, and some have poor solvation and low loading resulting in a 
difficult synthesis. This chapter introduces a new resin that has entered the market. 
OctaGel™ resin (OG resin) is a unique highly uniform surface-active resin.  Sites on the 
interior of the resin beads are capped with PEG, leaving reactive sites only on the surface.  This 
ensures that peptide chain growth is not inhibited by steric factors within the pores of the resin 
beads and that reagents are easily accessible to all reaction sites.  In addition, OG resin has 
PEG chains of approximately 1500 MW bonded perpendicular to the surface of the beads. The 
PEG hydrogen bonds with the growing peptide chain to keep even highly hydrophobic peptide 




Figure 8: Peptide backbone hydrogen bonding with PEG. 
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A comparison study was conducted to determine the performance of three different resins 
towards the synthesis of two model peptide sequences. Two commonly used resins; Fmoc-
Rink-Amide Amino-methyl Polystyrene, (Fmoc-Rink-Amide Amino-methyl PS) and H-Rink-
Amide ChemMatrix®, (H-Rink-Amide CM) resin was used to compare the performance of a 
novel Fmoc-Rink-Amide PEG Octagel Surface resin 
Swelling studies were conducted on each resin using 10 different solvents and swelling 
calculations were measured (see results). The resin beads were imaged using microscopic 
techniques. SEM images of each resin was imaged as dry beads before its use in synthesis. 
Light microscopic images were taken of each resin, when dry and when submersed in solvents 
like DCM, DMF and 2-MeTHF. The model peptides, Aib-enkephalin pentapeptide and Aib-
ACP decapeptide (figure 9) were synthesized on each resin using N,N’-
Diisopropylcarbodiimide (DIC) and OxymaPure as coupling reagents. 
 
 








Each resin (200 mg) was placed in a 5-mL syringe, treated with enough solvent to swell the 
resin, and allowed to stand for 10 min with moderate stirring. The swollen resin was 
compressed with the piston of the syringe until no more solvent could be extracted. The piston 
was pulled slowly until the resin regained its maximum volume in the syringe, and the volume 
of the resin was read (the void volume of the tip and the syringe was averaged to 0.15 mL). 
The swelling was calculated according to the following formula:  
 







2.2.2. Optical imaging studies 
SEM was conducted on each of the resins at different magnifications (×25 and ×50). Each of 
the resins were dry when experiment was conducted. Light microscopy was also conducted on 
each of the resins. Beads of each resin were analysed as dry as well as under solvents of DCM, 
DMF and 2-MeTHF. A spatula full of each resin were placed onto slides and imaged under the 
microscope using ×40 magnification. Thereafter, a drop of each solvent was added to each slide 
and viewed under a microscope.   
Images were taken using a Leica ICC50 HD microscope with Leica Microsystems Application 
Suite version 2.1.0 software.  
2.2.3. SPPS 
The synthesis was carried out manually in a polypropylene syringe fitted with a polyethylene 
porous disc. 68 mg of Fmoc-RinkAmide-AM-PS resin (0.74 mmol/g), 113 mg of H-
RinkAmide-AM-CM resin (0.45 mmol/g) and 111 mg of Fmoc-RinkAmide-AM-PEG-OG 
resin (0.44 mmol/g) was used in the synthesis. The swelling of OG and CM resins was achieved 
as the following follows: MeOH (2×1 min), DMF (2×1 min), DCM (2×1 min), TFA-DCM  
(1:99) (2×1 min), DIEA-DCM (1:19) (2×1 min), and DCM (2×1 min) (5 mL each)[61].  
26 
 
The resin was treated with deprotection solution (20% piperidine in DMF), then washed by 
DMF (2×1 min), DCM (2×1 min), and DMF (2×1 min) (5 mL each). Fmoc amino acids 
derivatives (3 equiv.), OxymaPure (3 equiv.), and DIC (3 equiv.) in minimum amount of DMF 
were preactivated for 3 min then added to the resin in the first coupling process, and the mixture 
was shaken for 1 h. After complete coupling, the resin was washed by DMF (2×1 min), DCM 
(2×1 min), and DMF (2×1 min) (5 mL each) and then de-blocked by treatment with 
deprotection condition that mentioned above.  
The cycle was then repeated to obtain the target peptide with exception of the second Aib 
residue where double coupling was applied for 1 h in case of Aib-enkephalin pentapeptide and 
2 h in case of Aib-ACP decapeptide. The peptide was cleaved from the resin with 
TFA/TIS/H2O (95:2.5:2.5) at rt for 2 h. TFA was removed under nitrogen, and the crude 
peptide was precipitated with cold diethyl ether (Et2O) (3 × 10 mL). Then, the crude peptide 
was analyzed by HPLC and LC-MS (electrospray ionization). 
2.3. Results and Discussion 
2.3.1. Swelling 
Table 3. Swelling calculations for the three resins tested under 10 different solvents   
Entry Solvent Swelling (mL/g) 
PS CM OG 
1 DMF 5.5 8.25 6.25 
2 DCM 5.75 10.25 7.25 
3 MeCN 3.25 6.75 4.25 
4 THF 5.75 7.75 5.5 
5 2-MeTHF 4 6.25 5.25 
6 Dimethyl 
carbonate 
4.25 7 5.25 
7 γ – Valerolactone 5.25 6.75 5.5 
8 Cyclopentyl 
methyl ether 
3.75 3.75 3.75 
9 Propan-2-ol 3.25 3.75 3.75 
10 Water 3 6.75 3.75 
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Swelling is an indication of how well solvents or soluble reagents will interact with the resin 
to allow an easy synthesis of a peptide. Swelling results indicate that Fmoc-Rink-Amide PEG 
OG has a good swelling-solvent ratio especially in the standard solvents used for SPPS, (DCM 
and DMF). Overall, OG resin has a moderate level of swelling amongst the different solvents 
tested, by comparison.  
 
2.3.2. Scanning electron microscopy 
 
Image 1: SEM image of PS resin with diameter of smallest and largest bead 
 




Image 3: SEM image of OG resin with diameter of smallest and largest bead 
 
OG resin beads are of larger particle size (205.1 μm) compared to CM (155.1 μm) and PS 
(169.2 μm). This property shows its superiority amongst the others as a bigger particle size 
allows for increased surface area resulting in increased interactions of reagents and solvents 
with the growing peptide chain on the resin.  
OG also shows increased uniformity of its resin bead sizes (compared to CM and PS) providing 
an ease in filtration and washings in between peptide chain growth (see appendix A for more 
SEM images). This also helps in the isolation of the peptide from the resin. 
 
2.3.3. Light Microscopy 
A light microscope (Leica ICC50 HD) was used to sample each resin beads. Beads were placed 
on slides as dry samples. Thereafter each solvent was added to the slide and images were taken 
of the beads using Leica imaging software. Magnification was set at ×40 and images shown 





Image 4: PS beads under a light microscope in DCM, DMF and 2-Me-THF  
 




Image 6: OG beads under a light microscope in DCM, DMF and 2-Me-THF  
 
Based on observations using light microscopy, OG beads interacted well with DCM, DMF and 
2-MeTHF from the surface towards the interior of the bead (image 6). OG beads also show no 
damages such as dented tracts, as compared to CM (image 5 and image 6). Each of the beads 
swells around three times its original size (when dry) under DCM and DMF based on 
observations. 2-Me THF solvent hardly swells PS and CM beads but shows interaction with 
OG. 
 
2.3.4. HPLC and LCMS Analysis  
Aib-enkephalin pentapeptide: 
A linear gradient of 20–40% 0.1% TFA in CH3CN/0.1% TFA in H2O over 15 min was applied, 
with a flow rate of 1 mL/min and detection at 220 nm using an YMC-Triart C18 (3 μm, 3.0× 
150 mm) column, tR(pentapeptide) = 6.7 min, tR (des-Aib) = 7.01 min. LC–MS showed m/z 




A linear gradient of 10–50% 0.1% TFA in CH3CN/0.1% TFA in H2O over 15 min was applied, 
with a flow rate of 1.0 mL/min and detection at 220 nm using a Phenomex C18 (3 μm, 4.6 ×50 
mm) column, tR(decapeptide) = 6.9 min, tR(des-Aib) = 7.1 min. LC–MS showed m/z for the 
decapeptide as [M] = 1090.35 and [M – 2H+] = 1088.17. Mass of peptide 1090.25 
 
Table 4.  Percentage purity of Aib-enkephalin pentapeptide from HPLC 
Entry Resin Pentapeptide 
(%) 
des-Aib (%) 
1 PS 96.5 3.5 
2 CM 95.4 1.7 
3 OG 89.0 8.8 
 
 
Table 5. Percentage purity of Aib-ACP decapeptide HPLC 
Entry Resin Decapeptide 
(%) 
des-Aib (%) 
1 PS 91.1 4.2 
2 CM 86.2 4.7 
3 OG 95.4 2.0 
 
OG rendered the product in lower purity than PS and CM in case of Aib-enkephalin 
pentapeptide. The performance of the OG resin was better during synthesis of the longer 
peptide, Aib-ACP decapeptide. It rendered the product in higher purity than PS and CM resin 







Fmoc-Rink-Amide PEG OG resin has been successful in the synthesis of Aib-pentapeptide and 
Aib-ACP decapeptide with high purity of the decapeptide. Swelling results show that OG 
values falls in between PS and CM resins with synthetic results being similar to that of CM (in 
terms of yield and purity of the peptide sequence).  
The two peptides synthesized were ‘difficult’ sequences due to the Aib amino acids used in 
place of glycine residues. This amino acid was left to couple for a longer period, with double 
coupling on second Aib residue, than the others in the sequence, in all three resins used. Octagel 
resin gave poor results in the case of Aib-pentapeptide by forming des-Aib tetrapeptide as a 
side product, based on HPLC analysis. This resulted in a low purity of the desired pentapeptide. 
This observation also would indicate that the synthesis of Aib-ACP decapeptide, on Octagel, 
would form the des-Aib nonapeptide more prevalent, however in our case it did not. This may 
be due to a good and stable interaction of the amino acids in the peptide interaction with the 
surface of the resin (Octagel).         
The resin beads of OG resin are of superior quality based on imaging results obtained. Overall 
OG resin shows great potential in synthesizing peptide sequences with high purity. 
2.5. Future work 
Exploring the use of OG resin in the synthesis of longer peptide sequences, as well as green 
solvent peptide synthesis. 
2.6. References 
1. Information about Octagel was provided via personal correspondence with Aaptec 
Biotechnology 
2. Garcia-Ramos, Y., et al., ChemMatrix (R) for complex peptides and combinatorial 














1. Preparation of protecting groups 
Three diphenyl type protecting groups were selected as they are cheap and relatively 
inexpensive to derivatize. Scheme 10 below shows how modifications to these groups were 
made to allow easy attachment to the histidine amino acid. 
 
 
Scheme 10: Synthetic steps used to obtain the necessary protecting group 
 
PG-1 (benzhydryl chloride) and PG-3 (4,4-dimethoxybenzhydryl chloride) 
Compounds 1 and 4 from scheme 10 (500 mg, 2.7 mmol) were dissolved in DCM (25 ml) and 
stirred. Thionyl chloride (SOCl2) (0.3 mL, 3 mmol) was added dropwise to the reaction mixture 
and was stirred under rt for 5 h. Upon completion, solvent and excess SOCl2 was removed 
under rotary evaporation to yield PG-1 as a pale-yellow liquid and PG-3 as a pink solid[62].  
PG-2 (4,4-dimethylbenzhydryl chloride) 
Compound 2 (500 mg) was first reduced to 3[63] and then it was converted to PG-2 using the 
same method above as a pale-yellow crystalline solid. 
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Three approaches were carried out as attempts to attach the protecting groups to Fmoc-His-
OH.  
Attempt 1: 
1. Removal of trityl group from Fmoc-His(trt)-OH 
 
Scheme 11: Step 1 in attempt 1 
Fmoc-His(trt)-OH (1) (500 mg, 0.81 mmol) was dissolved in DCM (10 mL) and stirred. To 
this, 2.5 mL TFA were added dropwise and the resulting solution was stirred for 1.5 h  (TLC 
5% MeOH in DCM). Work up of reaction was done by removal of solvent and acid under 
rotary evaporation. The concentrated sample was washed with cold Et2O (15 mL ×5). After 
decanting of Et2O, the product obtained was left to dry under bench vacuum to yield (2) (398 
mg) as white solid (84% yield). 
 
2.  Attaching protecting group to Fmoc-His-OH 
 
Scheme 12: Step 2 in attempt 1 
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Fmoc-His-OH (50 mg) (2) (1 equiv.) and the protecting group (PG) (1 equiv.) was dissolved 
in DCM. Thereafter triethylamine (3 equiv.) was added to the reaction and the mixture was 
stirred and monitored using TLC.  
Attempt 2:  
1. Protection of carboxy group using Pac-Br 
 
Scheme 13: Step 1 in attempt 2 
Fmoc-His(Trt)-OH (1 equiv.) and PacBr (1.5 equiv.) was dissolved in tetrahydrofuran (THF) 
in a 50 mL microwave vessel. Thereafter, TEA (3 equiv.) was added to the dissolved solution. 
The reaction was stirred under microwave conditions for 1.5 h at 60 °C. After completion, work 
up was done by dissolving in EtOAc and washing with H2O (×3) and brine solution (×3). The 
organic layer was collected and dried under MgSO4. The organic layer was filtered and 
concentrated under rotary evaporation. Purification using neutral alumina column under 
EtOAc:Hexane (60:40) yielded compound 3 (Fmoc-His(Trt)-O-Pac) as yellow gummy (407 
mg) (62% yield) 
 




Scheme 14: Step 2 in attempt 2 
Fmoc-His(Trt)-O-Pac (407 mg) (3) was dissolved in DCM (10 mL) and stirred. To this stirred 
solution, TFA (5 mL) was added dropwise and the reaction was stirred at rt for 2h (based on 
TLC analysis: 5% MeOH in DCM). Work up of the reaction is done by removal of solvent 
(CH2Cl2) and TFA under rotary evaporation. The concentrated sample was then washed with 
cold Et2O (15mL ×5) until powder was formed. After decanting of Et2O layer, the sample was 
dried under bench vacuum to yield compound 4 an off-white powder (50% yield, 258 mg). 
 
3. Attaching protecting group to Fmoc-His-O-Pac 
 
Scheme 15: Step 3 in attempt 2 
 
Fmoc-His-O-Pac (1 equiv.) and the corresponding protecting group (1 equiv.) was dissolved 
in DCM. Thereafter, TEA (3 equiv.) was added to the reaction mixture and stirred. The reaction 
was monitored using TLC.  
 
Attempt 3:  
The third attempt was an adaptation of a previous method by Barlos et al[49], in which the 




Scheme 16: Reaction mechanism of attempt 3 
 
Fmoc-His-OH (1 equiv.) was dissolved in dry DCM and stirred. Me3SiCl (1 equiv.) was added 
to mixture and the reaction was refluxed for 2 h. After this time, the reaction was removed from 
reflux, cooled to rt and added TEA (1 equiv.). The resultant solution was further refluxed for 5 
min and removed to cool at room temperature. A solution of the protecting group (1 equiv.) in 
DCM and TEA (2 equiv.) was added dropwise to the stirred reaction after attaining rt and the 
solution was stirred for 3 h.  
After reaction completion, work up was done as follows. Excess MeOH was added to the 
reaction mixture and was concentrated under rotary evaporation. The resultant residue was 
taken up with CHCl3 and was partitioned with a 5% citric acid solution. The organic layer was 
washed with a brine solution (×3) and collected and dried over MgSO4. The layer was filtered 
and concentrated to a small volume under rotary evaporation, and n-hexane was added 
dropwise to precipitate out the product. After decanting hexane, the crude yield obtained was 












Scheme 17: Activation of 2-CTC resin (1) and model peptide H-Gly-His-Phe-OH (2) 
 
Peptide synthesis 
2-CTC resin was activated as above and washed with dry DCM (5 mL ×5). The coupling of 
the first amino acid Fmoc-Phe-OH (2 equiv.) with DIEA, 2 equiv. in DCM (0.5 mL) was added 
to resin and stirred for 1 h. Thereafter, solvent was removed and MeOH (0.75 ml) was added 
and reaction was stirred for 0.5 h. The Fmoc group was then removed using 20% piperidine in 
DMF. 
Fmoc-amino acid derivatives (3 equiv.), OxymaPure (3 equiv.) and DIC (3 equiv.) in DMF 
(0.5mL) were preactivated for 3 min and then coupled onto the resin thereafter. At the end, the 
resin was washed with DMF (2×1 min), DCM (2×1 min) and DMF (2×1 min) (5 mL each) and 




3.3. Results and discussion 
All protecting groups, while monitoring using TLC, did not show full completion of reaction 
even when reaction is left for a longer period to stir. Based on proton NMR, product was formed 
regardless. 
Three attempts were carried out to try and attach PG1,2 and 3 onto Fmoc-His-OH. Each attempt 
was done parallelly as each PG wasn’t reacting towards Fmoc-His-OH and trying different 
experiments would likely improve results. Experiments with PG-1 and PG-2 were unsuccessful 
however as in each attempt, these groups did not react. 
In attempt 1: 
The removal of the Trt moiety from Fmoc-His(Trt)-OH in solution required 25% TFA in DCM. 
This was the optimal percentage used in removing Trt in 500 mg of Fmoc-His(Trt)-OH in 1.5 
h. Work-up resulted in a brownish gummy substance being formed. The addition of cold Et2O 
slightly precipitates the product out of solution. Mechanically grinding (trituration) of the 
compound with a spatula can increase the rate of precipitation of the desired product. A by-
product of this reaction is the Trt-OH molecule which is soluble in Et2O and can be removed 
while triturating the compound. Cold Et2O is added, triturated and decanted each time to allow 
for fresh Et2O to be added to dissolve away the Trt-OH by-product. This continuous process 
of washing can result in a lower yield of the product therefore it should be done carefully. 
HPLC analysis of the obtained product at 7.24 min in a linear gradient of 5-95% 0.1%TFA in 
CH3CN / 0.1% TFA in H2O over 15 min gave Fmoc-His-OH in 92% purity but after storing 
for a few months the purity dropped to 75% with a shift of retention to 8 min due to instrument 
technical difficulties (appendix B). 
When attaching the necessary protecting groups, it was found that PG-1 did not show reactivity 
towards Fmoc-His-OH even after stirring reaction under heat (water bath 35 °C) and overnight. 
Same result was obtained when PG-2 was used. The use of different solvents, as well as varying 
of the equivalent of base and protecting group in the reaction yielded the same result. In my 
hands, the reactions did not take place. A suspected reason was that the protecting groups had 
hydrolysed in solution during reaction and did not react. 
In the case of PG-3, after 1 h of stirring the reaction, there was a formation of compounds - 
based on TLC analysis, (4% MeOH in DCM mobile phase) with Rf = 0.26, 0.24, 0,21. 
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However, several attempts in purifying the crude reaction resulted in no isolation the compound 
due to mechanical loss during purification. With the goal of attaching a protecting group on the 
imidazole group I focussed on the other attempts. 
In attempt 2:  
The aim was to temporarily protect the carboxylic end of Fmoc-His-OH and then to attach the 
necessary protecting group to the imidazole side chain. The Pac moiety was selected as this 
group is known to be stable in strong aqueous acids and alkali but is selectively removed with 
zinc dust in acetic acid (AcOH) or with photolysis[46].  
Phenacyl group was attached to Fmoc-His(Trt)-OH under basic conditions to allow the 
formation of Fmoc-His(Trt)-O-Pac as the major product. 
However, with the development of a protecting group for histidine suitable for Fmoc/t-Bu 
peptide synthesis in mind, this approach is too tedious. It requires the release of the Pac moiety 
after side chain protection to allow a free carboxyl end to be activated for peptide bond 
formation. The increase in synthetic steps and the potential use of zinc dust which could leave 
traces of zinc in peptide synthesis makes this an unreliable approach hence I did not move 
forward in attaching the protecting groups. 
In attempt 3: 
This procedure is an adaptation of a “one-pot” synthesis of N-Trt-amino acids[4949]. Fmoc-
His-OH amino acid was used instead of the free amino acid derivative as per initial procedure 
and the trityl chloride was replaced with the synthesized protecting groups (PGs). In the case 
of PG-1 and PG-2, work up of the reaction resulted in precipitation of the compound in low 
yield (≤ 5%) in a 200 mg reaction. While carrying out the work-up, partitioning the crude with 
5% citric acid resulted in precipitate forming in the citric acid wash. Upon further analysis, it 
was seen based on HPLC analysis that the precipitate formed was that of the unreacted Fmoc-
His-OH. This proves that PG-1 and PG-2 have been hydrolysed and did not partake in the 
reaction. 
When PG-3 was used in the synthesis, there was no presence of unreacted Fmoc-His-OH found 
in the citric acid wash. Furthermore, after work up of the reaction, the crude was obtained in 
85% yield. A HPLC analysis of the crude shows that N τ-Fmoc-His(PG-3)-OH is the major 
compound (55%) as the major component(see appendix B). 
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Further purification using silica gel column chromatography of the crude was unsuccessful as 
a mixture of N-τ Fmoc-His(PG-3)-OH and Fmoc-His(PG-3)-O-PG3 was recovered (60% 
yield). LC/MS data confirmed the respective masses of these compounds (appendix B). 
The crude, Fmoc-His(PG-3)-OH was used in a model peptide H-Gly-His-Phe-OH. The 
presence of Fmoc-His(PG-3)-O-PG3 in the crude will not interfere in the reaction, because it 
will not couple to the peptide since its protected at the carboxyl end. The model peptide was 
first synthesized using Fmoc-His(Trt)-OH on 2-CTC resin. Cleavage of this peptide from CTC 
was done using a cocktail of 95% TFA, 2.5% TIS and 2.5% H2O. The same cocktail was used 
in cleaving the peptide containing Fmoc-His(PG-3)-OH. Cleavage of the peptide containing 
Fmoc-His(Trt)-OH from resin showed the removal of the Trt group in 15 min after treatment 
of the cleavage cocktail.  
When the same conditions were applied for the tripeptide containing Fmoc-His(PG3)-OH, after 
15 min, the peptide still contained PG-3 on the His side chain. Prolonged treatments with the 
cleavage cocktail (1 h and 5 h) showed very little formation of the desired peptide without any 
side chain protection (see chromatogram 1). Keeping the peptide in the cleavage cocktail 
overnight has no significant difference in the results. Cleavage of PG-3 occurs at a low rate 
when attached to the peptide. 
Semi-preparative chromatography purification of the crude compound yielded approx. 10 mg 
of pure Fmoc-His(PG-3)-OH. NMR (1H and 13C) was obtained for the compound (see appendix 
B). The product, after NMR analysis was diluted in H2O and lyophilised to obtain Fmoc-
His(PG3)-OH in powder form. Acid lability tests were conducted on the amino acid using three 
acid cocktails; 100% TFA, 97.5% TFA with 2.5% H2O and 95% TFA with 2.5% H2O and 2.5% 
TIS. 
A 3.3 μM stock solution of Fmoc-His(PG3)-OH in DCM was made for analysis. 50 μL of the 
solution was added to three Eppendorf’s and solvent was removed (DCM). Thereafter each 
cleavage cocktail was added to separate Eppendorf’s and the reaction was monitored using 
HPLC at different time intervals. See chromatograms 2-4. The HPLCs indicate that PG-3 is 


















Chromatogram 2: Fmoc-His(PG3)-OH in 100% TFA during different time intervals 















Chromatogram 4: Fmoc-His(PG-3)-OH in 95% TFA, 2.5% H2O and 2.5% TIS at different time 
intervals 
                  2                     4                    6                    8                    10                  12                  14  min             
Fmoc-His-OH 








Attempts of attaching a protecting group on Fmoc-His-OH amino acid was successful for only 
one of the functionalities used, PG-3. The 4,4-dimethoxydiphenyl moiety (PG-3) was 
suspected to behave like the trityl moiety in terms of acid lability however based on the results 
obtained, PG-3 showed a high stability towards high percentages of TFA with and without the 
use of scavenger’s H2O and TIS even after 4 h in the cleavage solution. The crude Fmoc-
His(PG3)-OH from attempt three was successfully used to create the model peptide H-Gly-
His-Phe-OH. Cleavage of the peptide from CTC resin indicated that PG-3 was still attached to 
the His residue after cleavage (see appendix B HPLC and LC/MS results).  
 
3.5. Future work 
Optimize the reaction and purification of attempt 3 with the use of PG-3 and develop a cleavage 
condition to remove PG-3 from Fmoc-His-OH 
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ChemMatrix × 50 
 
 




Octagel × 50 
 
 















































































































4,4-dimethyl diphenyl chloride (PG-2) 1H NMR in CDCl3 expanded 
 
 









Chlorodiphenylmethane (PG-1) 1H NMR in CDCl3 
 
 




























Gradient elution: 5 – 95% of solvent A to solvent B in 15 min 
Solvent A: 0.1% TFA in MilliQ H2O  Solvent B: 0.1% TFA in acetonitrile 
Fmoc-His-OH (first isolation) 
 
 






























Acid lability study 
HPLC conditions: 5 – 95% gradient elution of solvent B to solvent A in 15 min 
Solvent A: 0,1% TFA in MilliQ H2O  Solvent B: 0.1% TFA in Acetonitrile 
 








































































































































High Resolution Mass Spectrometry (HRMS):  
Fmoc-His(PG3)-OH 
Theoretical mass: C36H33N3O6 [M + H] = 604.240190 






LC/MS data  
Mobile phase: 5-95 % of solvent B to solvent A 
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